Home › Immune System and Disorders › Missouri
Immune System and Disorders clinical trials in Missouri
6 studies for Immune System and Disorders are looking for participants at sites in Missouri.
Cities in Missouri
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- MidAmerica Cancer Center, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- and 23 more
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- MidAmerica Cancer Center, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Washington University School of Medicine - Oncology Hospital - Public, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07192471Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- Washington University School of Medicine, St Louis
RecruitingPhase 1/2
1 Day – 21 Years · All sexes · Updated May 29, 2026 · NCT03128996A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Washington University School of Medicine - Siteman Cancer Center, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.